Changes in Hong Kong stocks | Deshi-B (02526) rose nearly 9% in early trading, and the company was included in 23 Hang Seng Indices

The Zhitong Finance App learned that Deshai-B (02526) rose nearly 9% in early trading. As of press release, it had risen 8.24% to HK$473, with a turnover of HK$11.665 million.

According to the news, Deshi has been included by Hang Seng Index Limited as the 23 constituent stocks of the Hang Seng Index, including the Hang Seng Composite Index and the Hang Seng Biotech Index, which took effect from September 7 and September 14, and the Hang Seng Hong Kong Stock Connect Artificial Intelligence Themed Index, which also took effect on September 14. The company has met the criteria for inclusion in Hong Kong Stock Connect transactions, and Deshi is the only company included in the Hang Seng Biotech Index in this index adjustment, marking the market's high recognition of its technical strength and industry position in the AI-enabled medical field.

Open Source Securities released a research report stating that Deshi is actively deploying the iMediimage® medical imaging base model to promote the upgrading of the business model from traditional medical imaging software to an AI medical platform. The company is expected to benefit from the increase in AI medical penetration rate and the implementation of large model applications. The company's revenue for 2026-2028 is estimated to be 4.9/9.3/1.72 billion yuan, respectively, giving it a “buy” rating for the first time. It is worth noting that Deshi's revenue in 2025 is 164 million yuan, which means that the agency expects the company's revenue to increase tenfold in three years.